Senior Management

Anthony J. Giovinazzo, M.B.A., C.Dir.

President & Chief Executive Officer

Mr. Giovinazzo has 31 years of experience in international investment and operating management, with an emphasis in strategy, mergers and acquisitions, financial management and business development. He has been involved in the neuroscience field since 1994.

He is currently the President and CEO of Cannasat Therapeutics, a clinical stage company listed on the Toronto Venture Exchange (TSX-V: CTH). Most recently, he was the Founder, President and CEO of Cervelo Pharmaceuticals, a venture backed company that raised US $36 million in October 2007. Before Cervelo he was the Chief Executive Officer of Cita NeuroPharmaceuticals Ltd., which in-licensed Phase 2 and Phase 3 assets from a European pharmaceutical company. In December 2005, Cita was sold to a UK public company for an above market return to the investors. From late 1994 to 1997, Anthony was President of the Neuroscience Partners Fund and a Vice President and Partner at MDS Capital Corp. For 15 years, prior to joining MDS Capital Corp., he focused on international corporate tax, merchant banking and venture capital investing in Europe and the US.

Mr. Giovinazzo is a Chartered Director (C. Dir.). He completed the Leadership and Strategy in Pharmaceuticals and Biotech Program of the Harvard Business School in June 2006. He is a member of the Institute of Corporate Directors of Canada, and an Overseas Member of the Institute of Directors of England.

In 2007, he was appointed a member of the expert panel advising the National Research Council of Canada on its Phase 4, Genomics Funding Program, for 3 years.